Full-Time

Molecular Technologist I

Posted on 4/30/2024

Tempus

Tempus

1,001-5,000 employees

AI-enabled precision medicine and analytics

AI & Machine Learning
Data & Analytics

Junior

Chicago, IL, USA

Requirements
  • MS in medical technology, clinical laboratory science, chemical, physical or biological science and 1 year pertinent clinical laboratory experience with molecular biology
  • BS in medical technology, clinical laboratory science, chemical, physical or biological science and 1 year of pertinent clinical lab experience in molecular biology
  • Excellent communication skills
  • Thrives in a fast-paced environment
  • Ability to work with others to plan and carry out scientific programs
  • Self-driven and works well in an interdisciplinary team with minimal direction
  • Strong desire to build products that will save lives and change the course of cancer
  • Impeccable attention to detail
  • Experience with next-generation sequencing
  • Work in a CLIA/CAP high-complexity laboratory
  • Experience with robotics and automated liquid handling systems
  • Knowledge of LIMS platforms and various computer systems
Responsibilities
  • Perform routine testing, quality control, calibration, maintenance, and proficiency testing in accordance with current laboratory procedures
  • Perform complex molecular-based procedures with a high degree of quality and in accordance with established protocols
  • Perform next-generation sequencing procedures
  • Sterilizing laboratory equipment and workspaces
  • Entering clinical patient data into the Laboratory Information Management system
  • Obtain 12 continuing education hours in the field of oncology or molecular biology
  • Maintain competency to perform all assigned molecular biology protocols in accordance with CAP, CLIA, NYSDOH regulations

Tempus specializes in AI-enabled precision medicine, utilizing data and artificial intelligence to accelerate the discovery of novel targets, predict treatment effectiveness, identify clinical trials, and diagnose diseases earlier. The company's analytical machine learning platform leverages expansive clinical and molecular data to enable real-time, data-driven decisions for personalized care and targeted therapies.

Company Stage

Series G

Total Funding

$1.3B

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

6%

1 year growth

23%

2 year growth

51%